These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7193709)

  • 1. Inhibitory effect of O-alkylated analogues of oxytocin and vasopressin on human and rat myometrial activity.
    Melin P; Vilhardt H; Lindeberg G; Larsson LE; Akerlund M
    J Endocrinol; 1981 Feb; 88(2):173-80. PubMed ID: 7193709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasopressin effects on isolated non-pregnant myometrium and uterine arteries and their inhibition by deamino-ethyl-lysine-vasopressin and deamino-ethyl-oxytocin.
    Akerlund M; Kostrzewska A; Laudănski T; Melin P; Vilhardt H
    Br J Obstet Gynaecol; 1983 Aug; 90(8):732-8. PubMed ID: 6882706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and some pharmacological properties of 18 potent O-alkyltyrosine-substituted antagonists of the vasopressor responses to arginine-vasopressin.
    Manning M; Lammek B; Bankowski K; Seto J; Sawyer WH
    J Med Chem; 1985 Oct; 28(10):1485-91. PubMed ID: 4045923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxy analogues of oxytocin and of lysine-vasopressin.
    Bisset GW; Chowdrey HS; Hope DB; Nilwises N; Wälti M
    Br J Pharmacol; 1979 Dec; 67(4):575-85. PubMed ID: 519108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic antagonists of the myometrial response to vasopressin and oxytocin.
    Melin P; Trojnar J; Johansson B; Vilhardt H; Akerlund M
    J Endocrinol; 1986 Oct; 111(1):125-31. PubMed ID: 3783079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and some pharmacological properties of oxytocin and vasopressin analogues with sarcosine or N-methyl-L-alanine in position 7.
    Grzonka Z; Lammek B; Kasprzykowski F; Gazis D; Schwartz IL
    J Med Chem; 1983 Apr; 26(4):555-9. PubMed ID: 6187921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine blood flow and myometrial activity at menstruation, and the action of vasopressin and a synthetic antagonist.
    Hauksson A; Akerlund M; Melin P
    Br J Obstet Gynaecol; 1988 Sep; 95(9):898-904. PubMed ID: 3191063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analogues of arginine vasopressin modified in position 2 or 3 with naphthylalanine: selective antagonists of oxytocin in-vitro.
    Sobocińska M; Lempicka E; Konieczna E; Derdowska I; Lammek B; Melhem S; Kozik W; Janecka J; Janecki M; Trzeciak HI
    J Pharm Pharmacol; 2000 Sep; 52(9):1105-12. PubMed ID: 11045891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonist and antagonist specificities of decidual prostaglandin-releasing oxytocin receptors and myometrial uterotonic oxytocin receptors in pregnant rats.
    Chen DL; Chan WY; Manning M
    J Reprod Fertil; 1994 Nov; 102(2):337-43. PubMed ID: 7861386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of vasopressin effects on the uterus by a synthetic analogue.
    Akerlund M; Strömberg P; Forsling ML; Melin P; Vilhardt H
    Obstet Gynecol; 1983 Sep; 62(3):309-12. PubMed ID: 6877687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some pharmacological properties of a synthetic oxytocin analogue [1-N-carbamoyl-hemicystine-2-O-methyltyrosine]-oxytocin (carbamoyl-methyloxytocin), an antagonist to the neurohypophysial hormones.
    Bisset GW; Clark BJ; Krejcí I; Polácek I; Rudinger J
    Br J Pharmacol; 1970 Oct; 40(2):342-60. PubMed ID: 4321760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxytocin and lysine-vasopressin with N5,N5-dialkylglutamine in the 4 position: effect of introducing sterically hindered groups into the hydrophilic cluster of neurohypophyseal hormones.
    Stahl GL; Smith CW; Walter R; Tsegenidis T; Stavropoulos G; Cordopatis P; Theodoropoulos D
    J Med Chem; 1980 Feb; 23(2):213-7. PubMed ID: 7359537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the non-peptide inhibitor OPC-21268 on oxytocin and vasopressin stimulation of rat and human myometrium.
    Atke A; Vilhardt H; Hauzerova L; Barth T; Andersen LF
    Eur J Pharmacol; 1995 Jul; 281(1):63-8. PubMed ID: 8566118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of four oxytocin analogues to myometrial oxytocin and arginine-vasopressin binding sites in pregnant women.
    Rydén G; Andersson RG; Berg G; Karlsson SG; Oscarsson Y
    Gynecol Obstet Invest; 1990; 29(1):6-9. PubMed ID: 2161784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxytocin- and vasopressin-binding sites in the rat uterus: competition binding and inhibitory pA2 studies with oxytocin and oxytocin antagonists.
    Chan WY; Cao L; Hill PS; Hruby VJ
    Endocrinology; 1990 Apr; 126(4):2095-101. PubMed ID: 2318158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurohypophysial peptides and the hippocampus. II. Excitation of rat hippocampal neurones by oxytocin and vasopressin applied in vitro.
    Tiberiis BE; McLennan H; Wilson N
    Neuropeptides; 1983 Dec; 4(1):73-86. PubMed ID: 6669225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained effects on synthetic ovarian steroids of rat myometrial contractility.
    Parkington HC; Lipton A
    J Endocrinol; 1976 Aug; 70(2):223-7. PubMed ID: 965882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent antagonists of the antidiuretic responses to arginine-vasopressin based on modifications of [1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid),2-D- phenylalanine,4-valine]arginine-vasopressin at position 4.
    Manning M; Olma A; Klis WA; Seto J; Sawyer WH
    J Med Chem; 1983 Nov; 26(11):1607-13. PubMed ID: 6631916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of vasopressin and oxytocin receptors in the rat uterus and vascular tissue.
    Anouar A; Clerget MS; Durroux T; Barberis C; Germain G
    Eur J Pharmacol; 1996 Jul; 308(1):87-96. PubMed ID: 8836636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine effects of N-alpha-triglycyl-(8-lysine)-vasopressin and 8-lysine-vasopressin in the first trimester of pregnancy.
    Laudański T; Akerlund M
    Contraception; 1980 Aug; 22(2):199-208. PubMed ID: 7449382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.